BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36997061)

  • 1. The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease.
    Akhouri V; Majumder S; Gaikwad AB
    Life Sci; 2023 May; 321():121643. PubMed ID: 36997061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
    Jayaprakash S; Hegde M; BharathwajChetty B; Girisa S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression.
    Sinha A; Iyengar PV; Ten Dijke P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM18-Regulated STAT3 Signaling Pathway
    Chen Q; Gao C; Wang M; Fei X; Zhao N
    Front Physiol; 2021; 12():709506. PubMed ID: 34434118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
    Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
    Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
    Wang Y; Argiles-Castillo D; Kane EI; Zhou A; Spratt DE
    J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32265230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth.
    Xu K; Chu Y; Liu Q; Fan W; He H; Huang F
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives.
    Zhang R; Shi S
    Mol Med; 2023 Mar; 29(1):34. PubMed ID: 36918822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.
    Jeong Y; Oh AR; Jung YH; Gi H; Kim YU; Kim K
    Exp Mol Med; 2023 Oct; 55(10):2097-2104. PubMed ID: 37779139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-154-5p Affects the TGF
    Bian C; Luan Z; Zhang H; Zhang R; Gao J; Wang Y; Li J; Ren H
    Oxid Med Cell Longev; 2022; 2022():7502632. PubMed ID: 35126820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NEDD4 ubiquitin E3 ligase: a snapshot view of its functional activity and regulation.
    Sicari D; Weber J; Maspero E; Polo S
    Biochem Soc Trans; 2022 Feb; 50(1):473-485. PubMed ID: 35129615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3 ubiquitin ligase: A potential regulator in fibrosis and systemic sclerosis.
    Huang XL; Zhang L; Duan Y; Wang YJ; Zhao JH; Wang J
    Cell Immunol; 2016; 306-307():1-8. PubMed ID: 27406900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy.
    Lin Z; Li S; Xiao H; Xu Z; Li C; Zeng J; Wang S; Liu Z; Huang H
    Cell Rep; 2023 Aug; 42(8):112851. PubMed ID: 37481723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of SMURFs in non-cancerous diseases.
    Wang D; Zou Y; Huang X; Yin Z; Li M; Xu J; Wu B; Li D; Zhang Y; Sun Y; Zhang X; Zhang N
    FASEB J; 2023 Aug; 37(8):e23110. PubMed ID: 37490283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
    Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
    J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
    Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
    Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.